跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 961 条关于
“opti-ox”
全部
961
临床试验
801
药物
129
机构
4
资讯
27
上个月
bit.bio Launches ioScreen CRISPR Screening Platform and Appoints First Chief Technology Officer
3个月前
Parse Biosciences and bit.bio Form Strategic Alliance to Map Cell Identity for AI-Driven Drug Discovery
8个月前
bit.bio Secures $50 Million Series C Funding to Advance Human Cell Programming Technology for Drug Discovery
2年前
OmRx Oncology Launches Phase 2 Trial of Oral Checkpoint Inhibitor OX-4224 for NSCLC
去年
OmRx Oncology Launches Phase 2 Trial of Novel Oral PD-L1 Inhibitor for NSCLC, Targeting Global Access Disparities
上个月
CTx001 Gene Therapy Shows Early Tolerability and Slowed Lesion Progression in Geographic Atrophy
去年
Karnataka Government Seeks DCGI Investigation Into HCG Clinical Trial Ethics Violations
前天
Optimi Health to Launch Health Canada-Authorized Phase 3 Trial of MDMA-Assisted Therapy for PTSD
去年
Kyowa Kirin to Present Phase 3 Rocatinlimab Results for Atopic Dermatitis at EADV 2025
2年前
OcuDyne's OPTiC System Shows Promise in Geographic Atrophy Pilot Study
第 1 页,共 3 页
上一页
下一页